Follow us:
UP-COMING WEBINAR - Deuterium in the 21st century, use in medicinal chemistry and synthetic methods
Online, 2nd March 2021, 4 pm CET
In this webinar, Thomas Jennequin will present insights on the use of Deuterium in medicinal chemistry and the advantages of having some deuterated positions on APIs. For instance, Deuterium can modify drug metabolization, pharmacokinetics, or toxicity. Thomas will highlight some of the challenges...
Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation
The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...
NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima
EASY: a disruptive mAb purification process to reduce cost of goods
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
Download
© Ypso-Facto 2014 - Powered by Ealys | Legal Information